27% growth in prescriptions dispensed over prior quarter; 147% growth over comparable quarter in 2022. 5 consecutive quarters of double-digit growth. Click here to learn more ›
Bremelanotide Is Safe and Well-Tolerated in Premenopausal Women With Hypoactive Sexual Desire Disorder (HSDD): Safety Results from the RECONNECT Studies
